BNR - Company ID 0001792267
The table below shows Burning Rock Biotech Ltd's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2022 |
|---|---|
| Cash & equivalents | $171.48M |
| Short-term investments | $0.00 |
| Receivables | $15.07M |
| Inventory | $19.36M |
| Total current assets | $218.44M |
| Property, plant & equipment | $44.98M |
| Goodwill | - |
| Total assets | $277.88M |
| Accounts payable | $8.43M |
| Total current liabilities | $53.66M |
| Long-term debt | - |
| Total liabilities | $64.05M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Retained earnings |
| -$410.90M |
| Total equity | $213.83M |